| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/09/2007 | CN1960989A Substituted oxazolobenzoisothiazole dioxide derivatives, production method and use thereof |
| 05/09/2007 | CN1960988A Compounds and compositions as protein kinase inhibitors |
| 05/09/2007 | CN1960985A Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 05/09/2007 | CN1960979A Triazolone derivatives as MMP inhibitors for the treatment of asthma and copd |
| 05/09/2007 | CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 05/09/2007 | CN1960971A Substituted pyrrolidine-2-ones |
| 05/09/2007 | CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists |
| 05/09/2007 | CN1960726A Composition comprising a jnk inhibitor and cyclosporin |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/08/2007 | US7214802 Anti-cytokine heterocyclic compounds |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214694 Controlling transforming growth facor; artificial skin; wound healing agents |
| 05/08/2007 | US7214691 For therapy of metabolic and eating disorders |
| 05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
| 05/03/2007 | WO2007050348A2 Potassium channel inhibitors |
| 05/03/2007 | WO2007049532A1 Aminodihydrothiazine derivative |
| 05/03/2007 | WO2007048732A1 Use of 5-aminopyrazoles for controlling phytopathogenic harmful fungi, novel 5-aminopyrazoles, process for their preparation and composition comprising them |
| 05/03/2007 | WO2007021982A3 Modulators of cystic fibrosis transmembrane conductance regulator |
| 05/03/2007 | WO2007009120A3 Heterotetracyclic compounds as tpo mimetics |
| 05/03/2007 | WO2006122011A3 Thiazole compounds and methods of use |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
| 05/03/2007 | US20070099976 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections |
| 05/03/2007 | US20070099964 1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease |
| 05/03/2007 | US20070099957 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 05/03/2007 | US20070099955 3-piperidinylisochroman-5-ols as dopamine agonists |
| 05/03/2007 | US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents |
| 05/03/2007 | US20070099937 Substituted Pyrrolones As Allosteric Modulators of Glucokinase |
| 05/03/2007 | US20070099936 Dihydroisoindolones As Allosteric Modulators Of Glucokinase |
| 05/03/2007 | US20070099929 Substituted thiophenes |
| 05/03/2007 | US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099916 nuclear hormone receptor inhibitors; to treat increased lipid levels, increased cholesterol levels, low HDL-cholesterol, high LDL-cholesterol, atherosclerotic diseases, diabetes, macular degeneration, Alzheimer's disease; 2-(1-benzyl-3-chloro-2-methyl-1H-indol-5-yl)-1,1,1,3,3,3-hexafluoro-propan-2-ol |
| 05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 05/03/2007 | US20070099908 Arylsulfonyl chromans as 5-HT6 inhibitors |
| 05/03/2007 | US20070099897 Therapeutic compounds |
| 05/03/2007 | US20070099895 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099874 Methods and compositions of novel triazine compounds |
| 05/03/2007 | CA2628074A1 Aminodihydrothiazine derivative |
| 05/02/2007 | EP1780211A2 Vanilloid receptor ligands and their use in treatments |
| 05/02/2007 | EP1780210A1 Novel cyclic aminobenzoic acid derivative |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778684A1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR |
| 05/02/2007 | EP1778678A1 Enantioselective process |
| 05/02/2007 | EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 05/02/2007 | EP1778676A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 05/02/2007 | EP1778669A2 Kinase inhibitors |
| 05/02/2007 | EP1778657A1 Fluorination process of protected aminothiazole |
| 05/02/2007 | EP1778643A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 05/02/2007 | EP1778642A1 5-ht7 receptor antagonosts |
| 05/02/2007 | EP1778641A1 5-ht7 receptor antagonists |
| 05/02/2007 | EP1778634A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/02/2007 | EP1778242A2 Compounds and compositions as modulators of steroid hormone nuclear receptors |
| 05/02/2007 | EP1778233A1 Intracellular receptor modulator compounds and methods |
| 05/02/2007 | EP1778229A2 Amido compounds and their use as pharmaceuticals |
| 05/02/2007 | EP1537111B1 Hetereoaryl nitrile derivatives |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1322608B1 Delta1-pyrrolines used as pesticides |
| 05/02/2007 | CN1956987A Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 05/02/2007 | CN1956984A 1,3,4-oxadiazol-2-ones as PPAR-delta modulators |
| 05/02/2007 | CN1956983A 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| 05/02/2007 | CN1956982A Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton |
| 05/02/2007 | CN1956981A Agent for treating keratoconjunctival trouble |
| 05/02/2007 | CN1956980A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956979A Thiazole derivative |
| 05/02/2007 | CN1956976A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956958A Aminopyridine derivatives as selective dopamine d3 agonists |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/01/2007 | US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor |
| 05/01/2007 | US7211673 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide |
| 05/01/2007 | US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/01/2007 | US7211668 PNA monomer and precursor |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211594 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 05/01/2007 | US7211593 Anticancer agents; antiproliferative agents; viricides; autoimmune diseases |
| 05/01/2007 | US7211591 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211576 Diaminothiazoles |
| 05/01/2007 | US7211545 Imidazo[1,2-a]pyrimidine and fungicidal compositions containing thereof |
| 05/01/2007 | CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents |
| 05/01/2007 | CA2162630C Sulfonamides |
| 05/01/2007 | CA2132131C 3-arylbenzofuranones as stabilisers |
| 04/26/2007 | WO2007047991A1 Tetrahydroisoquinoline as lxr modulators |
| 04/26/2007 | WO2007047737A1 Cb-1 modulating compounds and their use |
| 04/26/2007 | WO2007047474A2 Biphenyl derivatives as modulators of voltage gated ion channels |
| 04/26/2007 | WO2007047177A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/26/2007 | WO2007046868A2 Thiazolidine derivatives and their uses as therapeutic agents |
| 04/26/2007 | WO2007046550A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 04/26/2007 | WO2007045989A1 Pyridyl derivatives useful as h3 ligands |
| 04/26/2007 | WO2007045893A2 Beta adrenergic receptor pharmacophore |
| 04/26/2007 | WO2007045761A1 Amidine derivatives and their uses as medicine |
| 04/26/2007 | WO2007045339A1 Imidazole derivatives as inhibitors of tafia |
| 04/26/2007 | WO2007028118A3 Nicotinic acid and picolinic acid derived near-infrared fluorophores |
| 04/26/2007 | WO2007017511A3 Compounds for treating alzheimer's disease |